Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Journal of Neuropathology and Experimental Neurology
|
January 18, 2006
Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis
Alice Brockington, Stephen B Wharton, Malee Fernando, et al.
The British Journal of Ophthalmology
|
March 30, 2017
Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment
Anita S Y Chan, Hardeep Mudhar, Sunny Yu Shen, et al.
Oncotarget
|
July 30, 2014
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents
Abhijit A Patil, Parag Sayal, Marie-Lise Depondt, et al.
Cancers
|
March 6, 2021
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma
Natasha Carmell, Ola Rominiyi, Katie N Myers, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Journal of Neuropathology and Experimental Neurology
|
January 18, 2006
Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis
Alice Brockington, Stephen B Wharton, Malee Fernando, et al.
The British Journal of Ophthalmology
|
March 30, 2017
Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment
Anita S Y Chan, Hardeep Mudhar, Sunny Yu Shen, et al.
Oncotarget
|
July 30, 2014
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents
Abhijit A Patil, Parag Sayal, Marie-Lise Depondt, et al.
Cancers
|
March 6, 2021
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma
Natasha Carmell, Ola Rominiyi, Katie N Myers, et al.
Page
of 3